PHS
PFM Health Sciences’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,597
| Closed | -$2.17M | – | 76 |
|
|
2024
Q4 | $2.17M | Buy |
+17,597
| New | +$2.17M | 0.13% | 61 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 83 |
|
|
2022
Q4 | – | Sell |
-571,936
| Closed | -$76.2M | – | 80 |
|
|
2022
Q3 | $76.2M | Hold |
571,936
| – | – | 2.76% | 7 |
|
|
2022
Q2 | $89.2M | Buy |
571,936
+55,530
| +11% | +$8.66M | 3.4% | 5 |
|
|
2022
Q1 | $80.4M | Buy |
+516,406
| New | +$80.4M | 3.01% | 8 |
|
|
2018
Q4 | – | Sell |
-958,025
| Closed | -$161M | – | 109 |
|
|
2018
Q3 | $161M | Sell |
958,025
-280,881
| -23% | -$47.2M | 2.36% | 2 |
|
|
2018
Q2 | $213M | Buy |
1,238,906
+103,379
| +9% | +$17.8M | 3.34% | 1 |
|
|
2018
Q1 | $171M | Buy |
+1,135,527
| New | +$171M | 3.48% | 4 |
|
|
2017
Q2 | – | Sell |
-864,276
| Closed | -$125M | – | 95 |
|
|
2017
Q1 | $125M | Sell |
864,276
-68,847
| -7% | -$9.99M | 3.14% | 2 |
|
|
2016
Q4 | $102M | Sell |
933,123
-228,179
| -20% | -$24.9M | 2.87% | 3 |
|
|
2016
Q3 | $141M | Buy |
1,161,302
+651,321
| +128% | +$79.1M | 4.13% | 2 |
|
|
2016
Q2 | $72.1M | Sell |
509,981
-254,403
| -33% | -$35.9M | 2.17% | 8 |
|
|
2016
Q1 | $99.8M | Buy |
764,384
+252,534
| +49% | +$33M | 3.08% | 6 |
|
|
2015
Q4 | $71.9M | Buy |
511,850
+185,848
| +57% | +$26.1M | 2.19% | 16 |
|
|
2015
Q3 | $43.3M | Sell |
326,002
-139,412
| -30% | -$18.5M | 1.22% | 30 |
|
|
2015
Q2 | $81.9M | Sell |
465,414
-59,589
| -11% | -$10.5M | 2.07% | 15 |
|
|
2015
Q1 | $90.7M | Buy |
+525,003
| New | +$90.7M | 2.5% | 9 |
|